News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,855 Results
Type
Article (18143)
Company Profile (40)
Press Release (284671)
Multimedia
Podcasts (17)
Webinars (8)
Section
Business (81489)
Career Advice (162)
Deals (12632)
Drug Delivery (30)
Drug Development (37352)
Employer Resources (20)
FDA (5344)
Job Trends (4196)
News (135827)
Policy (10481)
Tag
2027 Biotech Bay Standard (2)
2027 Pharm Country Standard (2)
Academia (655)
Accelerated approval (14)
Adcomms (2)
Allergies (78)
Alliances (22202)
ALS (79)
Alzheimer's disease (553)
Antibody-drug conjugate (ADC) (186)
Approvals (5607)
Artificial intelligence (253)
Autoimmune disease (111)
Automation (20)
Bankruptcy (82)
Best Places to Work (3650)
Biosimilars (71)
Biotechnology (32)
Bladder cancer (110)
Brain cancer (25)
Breast cancer (387)
Cancer (2892)
Cardiovascular disease (204)
Career advice (140)
Career pathing (2)
CAR-T (185)
CDC (6)
Celiac Disease (1)
Cell therapy (407)
Cervical cancer (17)
Clinical research (32932)
Collaboration (901)
Compensation (465)
Complete response letters (16)
COVID-19 (2002)
CRISPR (50)
C-suite (446)
Cystic fibrosis (75)
Data (3783)
Denatured (1)
Depression (52)
Diabetes (205)
Diagnostics (2246)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (6)
Drug discovery (106)
Drug pricing (40)
Drug shortages (6)
Duchenne muscular dystrophy (88)
Earnings (25394)
Editorial (9)
Employer branding (2)
Employer resources (20)
Events (54238)
Executive appointments (587)
FDA (6983)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (848)
Gene editing (101)
Generative AI (14)
Gene therapy (256)
GLP-1 (317)
Government (1399)
Grass and pollen (6)
Guidances (230)
Healthcare (4921)
HIV (41)
Huntington's disease (22)
IgA nephropathy (61)
Immunology and inflammation (117)
Immuno-oncology (31)
Indications (52)
Infectious disease (2154)
Inflammatory bowel disease (91)
Inflation Reduction Act (5)
Influenza (76)
Intellectual property (102)
Interviews (30)
IPO (4983)
IRA (8)
Job creations (883)
Job search strategy (125)
JPM (15)
Kidney cancer (8)
Labor market (9)
Layoffs (104)
Leadership (1)
Legal (2384)
Liver cancer (50)
Longevity (4)
Lung cancer (392)
Lymphoma (332)
Machine learning (17)
Management (5)
Manufacturing (284)
MASH (97)
Medical device (2947)
Medtech (2960)
Mergers & acquisitions (8214)
Metabolic disorders (500)
Multiple sclerosis (102)
NASH (10)
Neurodegenerative disease (144)
Neuropsychiatric disorders (33)
Neuroscience (1112)
NextGen: Class of 2026 (1574)
Non-profit (626)
Now hiring (2)
Obesity (191)
Opinion (121)
Ovarian cancer (109)
Pain (93)
Pancreatic cancer (129)
Parkinson's disease (135)
Partnered (9)
Patents (192)
Patient recruitment (258)
Peanut (31)
People (34396)
Pharmaceutical (9)
Pharmacy benefit managers (9)
Phase 1 (11107)
Phase 2 (15123)
Phase 3 (10117)
Pipeline (2968)
Policy (40)
Postmarket research (1008)
Preclinical (3989)
Press Release (16)
Prostate cancer (145)
Psychedelics (9)
Radiopharmaceuticals (80)
Rare diseases (397)
Real estate (1733)
Recruiting (10)
Regulatory (8704)
Reports (9)
Research institute (644)
Resumes & cover letters (20)
Rett syndrome (20)
RNA editing (8)
RSV (44)
Schizophrenia (55)
Series A (126)
Series B (198)
Service/supplier (2)
Sickle cell disease (51)
Special edition (4)
Spinal muscular atrophy (60)
Sponsored (11)
Startups (1907)
Stomach cancer (4)
Supply chain (44)
Tariffs (18)
The Weekly (16)
Vaccines (502)
Venture capital (37)
Weight loss (101)
Women's health (34)
Date
Last 7 days (287)
Last 30 days (1014)
Last 365 days (15822)
2026 (1454)
2025 (16072)
2024 (14145)
2023 (13781)
2022 (19279)
2021 (22406)
2020 (19414)
2019 (10454)
2018 (7945)
2017 (14273)
2016 (16848)
2015 (21248)
2014 (15945)
2013 (13441)
2012 (13883)
2011 (13558)
2010 (11844)
Location
Africa (289)
Alabama (32)
Arizona (86)
Arkansas (7)
Asia (18767)
Australia (2786)
California (6054)
Canada (1504)
China (552)
Colorado (249)
Connecticut (290)
Delaware (228)
Europe (45100)
Florida (680)
Georgia (181)
Hawaii (3)
Idaho (16)
Illinois (490)
India (26)
Indiana (152)
Iowa (10)
Japan (261)
Kansas (51)
Kentucky (15)
Louisiana (7)
Maine (11)
Maryland (587)
Massachusetts (4453)
Michigan (106)
Minnesota (234)
Mississippi (1)
Missouri (58)
Montana (10)
Nebraska (4)
Nevada (82)
New Hampshire (22)
New Jersey (1591)
New Mexico (6)
New York (1448)
North Carolina (601)
North Dakota (4)
Northern California (3053)
Ohio (129)
Oklahoma (5)
Oregon (15)
Pennsylvania (938)
Puerto Rico (5)
Rhode Island (18)
South America (532)
South Carolina (8)
Southern California (2240)
Tennessee (57)
Texas (956)
United States (20032)
Utah (90)
Virginia (132)
Washington D.C. (27)
Washington State (517)
West Virginia (1)
Wisconsin (91)
Wyoming (1)
302,855 Results for "mucosis b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 15, 2025
·
3 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 20, 2026
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. to Present at Upcoming Conferences
November 3, 2025
·
3 min read
Press Releases
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
November 10, 2025
·
12 min read
Press Releases
Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system
Several recent steps move the closure toward commercialization: · New studies confirm the system’s usability and performance · Design now finalized and preparations for industrialization underway · Multiple new features set a new standard for luer lock closure systems
January 15, 2026
·
1 min read
Press Releases
Battelle Awarded U.S. EPA STREAMS V Contract to Deliver Nationwide Scientific, Technical, Research, Engineering, and Modeling Support
February 6, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates
December 4, 2025
·
10 min read
Press Releases
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
January 29, 2026
·
4 min read
1 of 30,286
Next
